Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.580
-0.080 (-4.82%)
At close: Jan 20, 2026, 4:00 PM EST
1.590
+0.010 (0.63%)
After-hours: Jan 20, 2026, 4:28 PM EST
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $9.66 million as of January 20, 2026. Its market cap has decreased by -71.69% in one year.
Market Cap
9.66M
Enterprise Value
161.49K
1-Year Change
-71.69%
Ranking
Category
Stock Price
$1.58
Market Cap Chart
Since March 17, 2021, Chemomab Therapeutics's market cap has decreased from $631.18M to $9.66M, a decrease of -98.47%. That is a compound annual growth rate of -57.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 10.22M | 0.61% |
| Dec 31, 2025 | 10.16M | -70.24% |
| Dec 31, 2024 | 34.13M | 466.14% |
| Dec 29, 2023 | 6.03M | -83.65% |
| Dec 30, 2022 | 36.88M | -53.12% |
| Dec 31, 2021 | 78.67M | -87.54% |
| Mar 17, 2021 | 631.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |